The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization (Q39961876)

15 September 2017

The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization (English)

1 reference

15 September 2017

0 references

1 reference

Burak Turgut

1

1 reference

15 September 2017

Mete Guler

2

1 reference

15 September 2017

Nusret Akpolat

3

1 reference

15 September 2017

Tamer Demır

4

1 reference

15 September 2017

Ulku Celıker

5

1 reference

15 September 2017

language of work or name

1 reference

7 December 2010

1 reference

15 September 2017

1 reference

15 September 2017

36

1 reference

15 September 2017

1

1 reference

15 September 2017

34-40

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

15 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Ocular angiogenesis: the role of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 inhibition of histamine release and cytokine production by mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 inhibits prostaglandin E2 production from synovial cells by suppressing peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Immunophilin-ligands FK506 and CsA inhibit HIF1alpha expression by a VHL- and ubiquitin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Angiogenesis and surgery: from mice to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Inflammation as a tumor promoter in cancer induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

Angiogenesis and chronic inflammation: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2010.516620

10.3109/02713683.2010.516620

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference